These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 28849389

  • 21. Effect of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Quality of Life in Patients with Peritoneal Mesothelioma.
    Ali YM, Sweeney J, Shen P, Votanopoulos KI, McQuellon R, Duckworth K, Perry KC, Russell G, Levine EA.
    Ann Surg Oncol; 2020 Jan; 27(1):117-123. PubMed ID: 31069554
    [Abstract] [Full Text] [Related]

  • 22. Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Acs M, Gerken M, Gajic I, Mayr M, Zustin J, Piso P.
    Langenbecks Arch Surg; 2022 Nov; 407(7):3057-3067. PubMed ID: 35732846
    [Abstract] [Full Text] [Related]

  • 23. Recurrence of Optimally Treated Malignant Peritoneal Mesothelioma with Cytoreduction and Heated Intraperitoneal Chemotherapy.
    Heller DR, Chiuzan C, Taub RN, Leinwand JC, Greene AM, Bates GE, Chabot JA, Kluger MD.
    Ann Surg Oncol; 2017 Dec; 24(13):3818-3824. PubMed ID: 29027138
    [Abstract] [Full Text] [Related]

  • 24. Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.
    Canda AE, Arslan C, Terzi C, Sokmen S, Yavuzsen T, Ozkardesler S, Unlu M, Obuz F, Fuzun M.
    World J Surg Oncol; 2018 Mar 27; 16(1):70. PubMed ID: 29587771
    [Abstract] [Full Text] [Related]

  • 25. Radiological predictors of complete cytoreduction in 59 patients with peritoneal mesothelioma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a UK referral centre.
    Chandramohan A, Thrower A, Shah N, Mohamed F.
    Br J Radiol; 2017 Nov 27; 90(1079):20170361. PubMed ID: 28830230
    [Abstract] [Full Text] [Related]

  • 26. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.
    Teo MC, Tan GH, Tham CK, Lim C, Soo KC.
    Ann Surg Oncol; 2013 Sep 27; 20(9):2968-74. PubMed ID: 23504144
    [Abstract] [Full Text] [Related]

  • 27. Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study.
    Malgras B, Gayat E, Aoun O, Lo Dico R, Eveno C, Pautrat K, Delhorme JB, Passot G, Marchal F, Sgarbura O, Ferron G, Goéré D, Andre T, Pocard M, RENAPE Network.
    Ann Surg Oncol; 2018 Oct 27; 25(11):3271-3279. PubMed ID: 29978366
    [Abstract] [Full Text] [Related]

  • 28. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M.
    Eur J Cancer; 2013 Oct 27; 49(15):3140-8. PubMed ID: 23831335
    [Abstract] [Full Text] [Related]

  • 29. Malignant peritoneal mesothelioma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is GLUT1 expression a major prognostic factor? A preliminary study.
    Hommell-Fontaine J, Isaac S, Passot G, Decullier E, Traverse-Glehen A, Cotte E, You B, Mohamed F, Gilly FN, Glehen O, Berger F.
    Ann Surg Oncol; 2013 Nov 27; 20(12):3892-8. PubMed ID: 23800898
    [Abstract] [Full Text] [Related]

  • 30. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y, Aycart S, Mandeli JP, Heskel M, Sarpel U, Labow DM.
    Surg Oncol; 2015 Sep 27; 24(3):264-9. PubMed ID: 26143715
    [Abstract] [Full Text] [Related]

  • 31. Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma: Canadian practices and outcomes.
    Deban M, Taqi K, Knapp GC, Soucisse M, Curry M, Sidéris L, Dubé P, Khaldi MA, Jedrzejko N, Porter G, Giacomantonio C, Hamilton T, MacNeill A, Mack L, Bouchard-Fortier A.
    J Surg Oncol; 2023 Sep 27; 128(4):595-603. PubMed ID: 37249154
    [Abstract] [Full Text] [Related]

  • 32. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
    Wu X, Li Z, Li Z, Jia Y, Shan F, Ji X, Bu Z, Zhang L, Wu A, Ji J.
    J Surg Oncol; 2015 Jun 27; 111(7):840-7. PubMed ID: 25864884
    [Abstract] [Full Text] [Related]

  • 33. A comprehensive review of childbearing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Papageorgiou D, Manatakis DK, Papakonstantinou K, Kyriazanos ID.
    Arch Gynecol Obstet; 2020 Oct 27; 302(4):793-799. PubMed ID: 32653946
    [Abstract] [Full Text] [Related]

  • 34. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures.
    Passot G, Vaudoyer D, Villeneuve L, Kepenekian V, Beaujard AC, Bakrin N, Cotte E, Gilly FN, Glehen O.
    J Surg Oncol; 2016 Jun 27; 113(7):796-803. PubMed ID: 27110915
    [Abstract] [Full Text] [Related]

  • 35. The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Deraco M, Baratti D, Hutanu I, Bertuli R, Kusamura S.
    Ann Surg Oncol; 2013 Apr 27; 20(4):1093-100. PubMed ID: 23456386
    [Abstract] [Full Text] [Related]

  • 36. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
    Valle SJ, Alzahrani N, Alzahrani S, Traiki TB, Liauw W, Morris DL.
    Surg Oncol; 2016 Sep 27; 25(3):315-20. PubMed ID: 27566038
    [Abstract] [Full Text] [Related]

  • 37. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival.
    Sugarbaker PH, Chang D.
    Eur J Surg Oncol; 2017 Jul 27; 43(7):1228-1235. PubMed ID: 28189456
    [Abstract] [Full Text] [Related]

  • 38. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer.
    Manzanedo I, Pereira F, Pérez-Viejo E, Serrano Á, Hernández-García M, Martínez-Torres B, Rihuete-Caro C, Calzas J, Cueto M.
    Minerva Ginecol; 2017 Apr 27; 69(2):119-127. PubMed ID: 27415829
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry.
    Arjona-Sanchez A, Aziz O, Passot G, Salti G, Esquivel J, Van der Speeten K, Piso P, Nedelcut DS, Sommariva A, Yonemura Y, Turaga K, Selvasekar CR, Rodriguez-Ortiz L, Sanchez-Hidalgo JM, Casado-Adam A, Rufian-Peña S, Briceño J, Glehen O.
    Eur J Surg Oncol; 2021 Jun 27; 47(6):1420-1426. PubMed ID: 33298341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.